Literature DB >> 2536256

Alveolar transfer and metabolism of eicosanoids in the rat.

J Y Westcott1, T J McDonnell, N F Voelkel.   

Abstract

Alveolar transfer of eicosanoids was studied in the rat after instillation of [3H] prostaglandins, leukotrienes, and arachidonate into the distal airways. The percentage of originally added label remaining in lung or lavage was determined 2 min after instillation, with the remainder of the label having been transferred out of the lung. Peptidoleukotrienes were found to be largely (greater than 85%) retained in the lung after 2 min, and even after 15 min, more than 50% of the added radiolabel remained in the lung. In clear contrast, greater than 90% of the radiolabeled prostaglandin (PG) D2 was removed from the lung within 2 min after instillation. PGE2, thromboxane B2, leukotriene (LT) B4, and 5-hydroxyeicosatetraenoic acid (5-HETE) were also quickly removed from the lung, with less than 30% of the added label remaining in the lung after 2 min. Arachidonic acid and 6-keto-PGF1 alpha were removed more slowly from the lung, with 40 to 70% remaining in the lung 2 min after instillation. The arachidonic acid remaining in the lung was largely esterified into phospholipids, especially phosphatidylcholine. The 5-HETE radiolabel remaining in the lung was also associated in part with phosphatidylcholine. The radioactivity remaining in the lung after [3H] LTB4, 6-keto-PGF1 alpha, PGD2, and thromboxane B2 instillation reflected predominantly unmetabolized eicosanoids. The peptidoleukotrienes underwent a slow metabolism from LTC4 to LTD4 to LTE4. In addition, LTE4 was metabolized to a more polar product with chromatographic properties identical to those of N-acetyl LTE4. Rat lung slices and homogenates also metabolized peptidoleukotrienes via this pathway, although less N-acetyl LTE4 was produced.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2536256     DOI: 10.1164/ajrccm/139.1.80

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  4 in total

Review 1.  The measurement of leukotrienes in human fluids.

Authors:  J Y Westcott
Journal:  Clin Rev Allergy Immunol       Date:  1999 Spring-Summer       Impact factor: 8.667

2.  Constitutive activation of 5-lipoxygenase in the lungs of patients with idiopathic pulmonary fibrosis.

Authors:  J Wilborn; M Bailie; M Coffey; M Burdick; R Strieter; M Peters-Golden
Journal:  J Clin Invest       Date:  1996-04-15       Impact factor: 14.808

3.  Inflammatory mediators and cellular infiltration of the lungs in a guinea pig model of the late asthmatic reaction.

Authors:  A F Walls; Y K Rhee; D J Gould; C Walters; C Robinson; M K Church; S T Holgate
Journal:  Lung       Date:  1991       Impact factor: 2.584

4.  Pulmonary hypertension in infants with congenital heart defects: are leukotrienes involved?

Authors:  A Serraf; J P Gascard; J Bruniaux; C Labat; C Planche; C Brink
Journal:  Mediators Inflamm       Date:  1997       Impact factor: 4.711

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.